Vr Adviser, LLC Galera Therapeutics, Inc. Transaction History

Vr Adviser, LLC

  • $966 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
SELL
$8.35 - $12.39 $7.66 Million - $11.4 Million
-917,860 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$8.02 - $12.81 $6.95 Million - $11.1 Million
866,207 Added 1676.97%
917,860 $9.39 Million
Q3 2020

Nov 16, 2020
BUY
$6.96 - $9.12 $359,504 - $471,075
51,653 New
51,653 $467,000

Others Institutions Holding GRTX

# of Institutions
2
Shares Held
909K
Call Options Held
0
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $1.07M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email